Press & Announcements
Press & Announcements

The 2017 Annual Report looks back at what we have accomplished over the year, as well as toward the goals that we have set for each of our programs over the next five to 10 years.
Read more
A clear understanding of the complex, ever-changing antiretroviral (ARV) and diagnostic markets in low- and middle-income countries is critical for all stakeholders in the HIV space. To address this need, CHAI publishes an annual HIV market report for public consumption based on aggregated market intelligence from our programmatic work in over 30 countries. We are...
Read more
Amsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the spread of disease, and reduces healthcare spending. The new agreement, announced today at the 2018 International AIDS Conference,...
Read more
We are delighted to announce the joint launch of a partnership to speed up development and introduction of optimized pediatric formulations of dolutegravir for children living with HIV in resource-limited settings. The new initiative includes an incentive program and is a key feature of Unitaid’s US$34 million Optimal Antiretroviral (ARV) grant to CHAI. The optimal...
Read more
Introducing the second edition of CHAI’s HIV Mid-Year Market Memo, an informational brief that covers the latest trends in the HIV space in low- and middle-income countries (LMICs) since the publication of CHAI’s annual ARV Market Report in September 2017. See the HIV Mid-Year Market Memo here. See the 2017 ARV Market Report here.
Read moreCHAI in the News
AI fortunes could bring critical funds to Global Health. The scramble is on.
US approval of cheap, generic HIV prevention shot may boost global rollout
CHAI CEO joins Theory of Change podcast to talk end of HIV, scaling AI for health
- Devex: Ghana’s nutrition reset: from donor dependence to government-owned care
- AP News: Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
- Independent: Children living with HIV ‘not getting treatment needed’ as aid cuts hit services
- STAT News: Global health groups push to make cheap generic versions of an HIV prevention drug sold by Gilead
- Devex: CHAI CEO Dr. Neil Buddy Shah named to Devex Power 50
- New York Times: Philanthropies strike a promising deal to turn back HIV
- The Independent: Inside the battle to end the Aids pandemic in the face of Trump’s cuts
- Devex: ‘We’re not seeing a rebound’: New data shows HIV services not recovering
- Devex: CHAI CEO urges fresh vision for global health amid aid cuts
- New York Times: The global threat of antibiotic resistance
- BBC: Three million child deaths linked to drug resistance, study shows
- Al Jazeera: Why is the world suffering from a penicillin shortage?
- Grist: How do you take clean AC mainstream? This global health organization has some ideas.
- Science: Plans to expand African vaccine production face steep hurdles
For press inquiries contact:
Corina Milic, Director of Communications
press@clintonhealthaccess.org